Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ3Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,862
Award facts
- Contract value 100% obligated
- $57,862.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $57,862.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pens on January 20, 2026, with a completion date of January 21, 2026. This contract, with no set-aside designation, represents a small but significant pharmaceutical procurement supporting federal medical supply needs. The vendor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) relationship with DLA Troop Support Medical (designated SPE2DX), valued at up to $1 billion through December 2026, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems globally.
AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal agencies including the Department of Veterans Affairs and Defense Logistics Agency. The Zepbound procurement aligns with the company's extensive portfolio supplying specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military treatment facilities and veteran healthcare programs. The DLA Medical Supply Chain continues to plan expansion of its Pharmaceutical Prime Vendor Global Program with Generation V contracts anticipated to involve multiple regional awards, positioning key vendors like AmerisourceBergen to maintain critical roles in federal pharmaceutical distribution.
Quick answers
Who was awarded contract SPE2DR26FJJ3Y?
SPE2DR26FJJ3Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FJJ3Y worth?
The government has obligated $57,862 on SPE2DR26FJJ3Y.
Is contract SPE2DR26FJJ3Y an order under another contract?
Yes. SPE2DR26FJJ3Y is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ3Y competed?
The extent of competition for SPE2DR26FJJ3Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award